Vineeta Singh, MD discusses gender-specific differences in primary and secondary stroke prevention, including an examination of gender-specific issues surrounding patient consent to receive an IV tissue plasminogen activator (tPA). Dr. Singh also explores post-stroke quality-of-life issues for women.
Related Presenters